Glencoe Software, a top company in bioimaging data solutions, continues to play a key role in supporting major pharmaceutical companies and leading research institutions around the world. With over 20 years of experience managing bioimaging data across both academic and industry settings, Glencoe remains a trusted partner in driving drug discovery and advancing scientific understanding through its powerful data tools. From secure on-premises setups to flexible cloud-based systems, the company enables the smooth management, analysis, and sharing of complex imaging data.
Health Technology Insights: Esperion’s Bempedoic Acid Gains Top ESC/EAS Dyslipidemia Rating
As part of its long-term growth strategy, Glencoe Software is undergoing a major leadership transition. Jason Swedlow, who founded the company and has led it as CEO and President since the beginning, is stepping into a new role as Chairman of the Board. This move marks a strategic step in Glencoe’s journey, allowing for the development of a new leadership team while maintaining strong continuity at the executive level.
The new Executive Team will consist of Emil Rozbicki and Erin Diel, who have been named Co-Presidents, alongside Chris Allan, who continues as Senior Vice President of Engineering. This leadership transition officially took effect on August 22, 2025. The team brings deep experience and a shared commitment to Glencoe’s mission, positioning the company for continued innovation and growth in the evolving bioimaging landscape.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 29 August 2025
Erin Diel, previously Head of Product, emphasized that Jason’s ongoing guidance will remain vital to the company’s progress. She noted that his move to the board highlights Glencoe’s focus on future growth while staying true to its core mission of delivering impactful bioimaging solutions. Emil Rozbicki, formerly Head of Applications, shared that his collaboration with Jason over the years has laid a strong foundation for this transition, and he sees the leadership culture at Glencoe as unified and forward-thinking.
Chris Allan, a founding team member, said it has been a privilege to help build the company with Jason and is enthusiastic about continuing that work in this new chapter. Jason Swedlow expressed pride in the team’s growth and readiness to take on greater responsibility, stressing that promoting talent from within reflects the company’s values and commitment to its clients. He believes the rapid expansion of the bioimaging field makes this the right time to bring fresh leadership perspectives to the forefront. Glencoe Software remains dedicated to supporting its global customer base with reliable, high-performance solutions and is focused on helping partners address increasingly complex imaging challenges in biomedical research and healthcare.
Health Technology Insights: American Nurses Association Alarmed by Sudden CDC Leadership Changes
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
